Earnings ·
Zomedica Corp. reported financial results for the quarter ended June 30, 2026, announcing record second-quarter…
ZOMDFZomedica Corp.
Zomedica Corp. reported financial results for the quarter ended June 30, 2026, announcing record second-quarter revenue of $9.5 million, a 37% increase year-over-year from $7.0 million. Net loss narrowed to $3.8 million from $7.4 million in the prior year period, while operating expenses declined 20% to $10.1 million due to disciplined cost management and the absence of non-cash impairment charges present in 2025. The company held $44.1 million in liquidity as of June 30, 2026, with cash burn improving by 38% to $3.4 million for the quarter. Zomedica operates in the animal health industry, providing innovative point-of-care diagnostic and therapeutic products for equine and companion animals.